indira gandhi child health institute formulary list...ministry of public health general directorate...

Ministry of Public Health

General Directorate of Curative Medicine

Directorate of Specialized and Tertiary Hospitals

Directorate of Ibn-e-Sina Chest Hospital

Formulary List

1st edition

May, 2017

Formulary List of Ibn-e-Sina Chest Hospital

ii Approved by Ibn-e-Sina Chest Hospital Drug & Therapeutic Committee


iii Approved by Ibn-e-Sina Chest Hospital Drug & Therapeutic Committee

ACRONYMS

FIPU Federation International Pharmaceutique Unit

g gram

IU international units

IV Intravenous

Lit liter

mcg microgram

mg milligram

ml milliliter

NPH Neutral Protamine Hagedron


1 Approved by Ibn-e-Sina Chest Hospital Drug & Therapeutic Committee

ANATOMO - THERAPEUTIC – CHEMICAL (ATC) CLASSIFICATION

A. ALIMENTARY TRACT AND METABOLISM

A02. DRUGS FOR ACID RELATED DISORDERS A02A. ANTACIDS

Aluminum hydroxide + magnesium trisilicate Tablet: 120 mg + 250 mg

A02B. DRUGS FOR PEPTIC ULCER AND GASTRO- ESOPHAGEAL REFLUX

DISEASE (GERD)

Omeprazole Capsule: 20 mg

Omeprazole Capsule: 40 mg

Omeprazole Injectable ampoule: 40 mg per vial

Pantoprazole Tablet: 20 mg

Pantoprazole Injectable ampoule: 40 mg per vial

Ranitidine Tablet: 150 mg

Ranitidine Injectable ampoule: 25 mg/ml, in 2 ml ampoule

A03. DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS A03B. BELLADONNA AND DERIVATIVES, PLAIN

Hyoscine (butylbromide, hydrobromide) Injectable ampoule: 20 mg /ml, in 1 ml ampoule

A03F. PROPULSIVES

Metoclopramide Tablet: 10 mg

Metoclopramide Injectable ampoule: 5 mg/ml in 2 ml ampoule

A06. LAXATIVES A06A. LAXATIVES

Lactulose Syrup: 3.33 g/5ml, in 150 ml bottle

Paraffin liquid Oral ingestion liquid

A10. DRUGS USED IN DIABETES A10A. INSULINS AND ANALOGUES



Insulin isophane (NPH) intermediate Injectable ampoule: 40 IU/ml, in 10 ml vial

Insulin isophane (NPH) intermediate Injectable ampoule: 100 IU/ml, in 10 ml vial

Insulin isophane (NPH) human+Regular human Injectable ampoule: 70%+30%

A10B. BLOOD GLUCOSE LOWERING MEDICINES, EXCLUDING INSULINS

Metformin Tablet: 500 mg

A11. VITAMINS A11A. Multivitamins, Combinations

Multivitamins and other minerals, including combinations

Multivitamins other combinations

B. BLOOD AND BLOOD FORMING ORGANS

B01. ANTITHROMBOTIC AGENTS B01A. ANTITHROMBOTIC AGENTS

Acetylsalicylic acid (Aspirin) (ASA) Tablet: 100 mg

Clopidogrel Tablet: 75 mg

Enoxaparin Injectable solution: 100 mg/ml in 1 ml ampoule

Heparin Injectable solution: 5000 IU/ml, in 1 ml ampoule

Reteplase Injectable vial: 10 IU per vial

Streptokinase Injectable ampoule: 1.5 MU per vial

Warfarin Tablet: 2 mg

B02. ANTIHEMORRHAGICS B02A. ANTIFIBRINOLYTICS

Tranexamic acid Injectable ampoule: 100 mg/ml, in 5 ml ampoule

B02B. VITAMIN K AND OTHER HEMOSTATICS

Phytomenadione (Vitamin K) Injectable ampoule: 10 mg/ml in 1 ml ampoule

B03. ANTIANEMIC PREPARATIONS



B03A. IRON PREPARATIONS

Ferrous sulfate + Folic acid (Vit B9) Tablet: 60 mg + 0.4 mg

B05. BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS B05A. BLOOD AND RELATED PRODUCTS

Fresh-frozen plasma Injectable solution: in 500 ml bottle

B05B. I.V. SOLUTIONS

Amino acid 10% Injectable solution: in 1000 ml bottle

Glucose Injectable solution: 25% in 10 ml

Glucose + Sodium chloride Injectable solution: 4%+0.18%, in 500 ml bottle




Mannitol Injectable solution: 10%, in 100 ml bottle

Mannitol Injectable solution: 20%, in 100 ml bottle

Ringer lactate (Compound Sodium Lactate Solution) Injectable solution: in 500 ml bottle

Ringer lactate (Compound Sodium Lactate Solution) Injectable solution: in 1000 ml bottle

Sodium chloride Injectable solution: 0.9%, in 500 ml bottle

Sodium chloride Injectable solution: 0.9%, in 1000 ml bottle

B05C. IRRIGATING SOLUTIONS





Sodium bicarbonate Injectable ampoule: 8.4%, in 10 ml vial

C. CARDIOVASCULAR SYSTEM

C01. CARDIAC THERAPY C01A. CARDIAC GLYCOSIDES

Digoxin Tablet: 0.25 mg

Digoxin Injectable solution: 0.25 mg/ml, in 2 ml ampoule



C01B. ANTIARRHYTHMICS, CLASS I AND III

Amiodarone Tablet: 200 mg

Amiodarone Injectable ampoule: 50 mg/ml, in 3 ml ampoule

C01C. CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES

Dobutamine Injectable solution: 12.5 mg/ml, in 20 ml vial

Dopamine Injectable solution: 40 mg/ml, in 5 ml vial

Epinephrine Injectable ampoule: 0.1%, in 1 ml ampoule

Norepinephrine Injectable solution: 2 mg/ml

C01D. VASODILATATORS USED IN CARDIAC DISEASES Glyceryl trinitrate (nitroglycerin) Tablet: 0.5 mg

Glyceryl trinitrate (nitroglycerin) Injectable solution: 5 mg/ml

Isosorbide dinitrate Tablet: 10 mg

C01E. OTHER CARDIAC PREPARATIONS

Adenosine Injectable solution: 3 mg/ml, in 2 ml ampoule

C02. ANTIHYPERTENSIVES C02D. ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON

Hydralazine Tablet: 25 mg

Hydralazine Tablet: 50 mg

Hydralazine Injectable ampoule: 20 mg/ml in 2 ml ampoule

C03. DIURETICS C03A. LOW-CEILING DIURETICS, THIAZIDES

Hydrochlorothiazide Tablet: 25 mg

Hydrochlorothiazide Tablet: 50 mg

C03C. HIGH-CEILING DIURETICS

Furosemide Tablet: 20 mg

Furosemide Tablet: 40 mg

Furosemide Injectable solution: 10mg/ml, in 2ml ampoule

C03D. POTASSIUM-SPARING AGENTS



Spironolactone Tablet: 50 mg

C03E. DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION

Spironolactone + Furosemide Tablet: 50 mg + 40 mg

C07. BETA BLOCKING AGENTS C07A. BETA BLOCKING AGENTS

Atenolol Tablet: 25 mg



Bisoprolol Tablet: 2.5 mg

Carvedilol Tablet: 6.25 mg

Labetalol Injectable solution: 5 mg / ml in 20 ml

Metoprolol Tablet: 50 mg

Metoprolol Injectable solution: 1 mg / ml in 5 ml

Propranolol Tablet: 10 mg

C08. CALCIUM CHANNEL BLOCKERS

C08C. SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS

Amlodipine Tablet: 5 mg

C08D. SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS

Diltiazem Tablet: 60 mg

Verapamil Tablet: 40 mg

Verapamil Tablet: 80 mg

Verapamil Injection solution: 2.5 mg/ml in 2 ml ampoule

C09. AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM C09A. ACE INHIBITORS, PLAIN

Captopril Tablet: 25 mg

Enalapril Tablet: 10 mg

Ramipril Tablet: 2.5 mg



C09C— ANGIOTENSIN II ANTAGONISTS, PLAIN Candesartan Tablet: 8 mg

Losartan Tablet: 50 mg

C09D. ANGIOTENSIN II ANTAGONISTS, COMBINATIONS Hydrochlorothiazide + losartan Tablet: 12.5 mg + 50 mg

C10. LIPID MODIFYING AGENTS

C10A. LIPID MODIFYING AGENTS, PLAIN

Atorvastatin Tablet: 20 mg

Rosuvastatin Tablet: 10 mg

D. DERMATOLOGICALS D08. ANTISEPTICS AND DISINFECTANTS D08A. ANTISEPTICS AND DISINFECTANTS

Chlorhexidine digluconate Topical solution: 5%

Chlorhexidine digluconate Topical solution: 7.1%

Chloroxylenol Topical solution: 4.8%

Povidone iodine Topical solution: 10%

Sodium hypochlorite (Chlorine) Topical solution: 5%

G. GENITO URINARY SYSTEM AND SEX HORMONES

G02. OTHER GYNECOLOGICALS G02C. OTHER GYNECOLOGICALS

Nifedipine Tablet: 10 mg

H. SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX

HORMONES AND INSULINS



H02. CORTICOSTEROIDS FOR SYSTEMIC USE H02A. CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN

Dexamethasone Injectable solution: 4 mg/ml, in 2 ml ampoule

Hydrocortisone sodium succinate Injectable ampoule: 100 mg/ vial

Methylprednisolone Table: 4 mg

Methylprednisolone Injectable solution: 40 mg/ml, in 1 ml ampoule

Prednisolone Tablet: 5 mg

H03. THYROID THERAPY H03A. THYROID PREPARATIONS

Levothyroxine Tablet: 0.05 mg

H03B. ANTITHYROID PREPARATIONS

Carbimazole Tablet: 5 mg

J. ANTIINFECTIVES FOR SYSTEMIC USE

J01. ANTIBACTERIALS FOR SYSTEMIC USE J01A. TETRACYCLINES

Doxycycline Capsule: 100 mg

J01C. BETA-LACTAM ANTIBACTERIALS, PENICILLINS

Amoxicillin Tablet: 500 mg

Amoxicillin + Clavulanic acid (Co-amoxiclav) Tablet: 500 mg + 125 mg

Ampicillin Injectable powder: 500 mg per vial

Ampicillin Injectable powder: 1000 mg per vial

Cloxacillin Capsule: 500 mg

Cloxacillin Injectable powder: 500 mg per vial

Penicillin Benzyl Benzathine Injectable vial: 1.2 MU/ vial

Penicillin Benzyl (Peni G) Injectable vial: 5 MU/ vial

Penicillin V (Phenoxy methyl Penicillin) Tablet: 250 mg



Penicillin V (Phenoxy methyl Penicillin) Tablet: 500 mg

Piperacillin + tazobactam Injectable vial: 4 g + 500 mg per vial

J01D. OTHER BETA-LACTAM ANTIBACTERIALS

Cefepime Injectable vial: 1 g/ vial

Cefixime Tablet: 400 mg

Cefotaxime Injectable vial: 1 g/ vial

Ceftriaxone Injectable vial: 1 g per vial

J01F. MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

Azithromycin Capsule: 250 mg

Azithromycin Capsule: 500 mg

Clarithromycin Tablet: 500 mg

Clindamycin Capsule: 150 mg

J01G. AMINOGLYCOSIDE ANTIBACTERIALS

Amikacin Injectable solution: 500 mg/ml, in 2 ml ampoule

Gentamicin Injectable solution: 40 mg/ml, in 2 ml ampoule

J01M. QUINOLONE ANTIBACTERIALS

Ciprofloxacin Tablet: 500 mg

Levofloxacin Tablet: 500 mg

Levofloxacin Injectable solution: 5 mg/ml, in 100 ml vial

Moxifloxacin Tablet: 400 mg

Nalidixic Acid Tablet: 500 mg

J01X. OTHER ANTIBACTERIALS

Metronidazole Injectable solution: 5 mg/ml, in 100 ml bottle

Nitrofurantoin Tablet: 100 mg

J04. ANTIMYCOBACTERIALS J04A. DRUGS FOR TREATMENT OF TUBERCULOSIS



Ethambutol (E) Tablet: 400 mg

Isoniazid (H) Tablet: 100 mg

Pyrazinamide (Z) Tablet: 500 mg

Rifampicin Tablet: 150 mg

M- MUSCULO-SKELETAL SYSTEM M01. ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS M01A. ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS

Diclofenac Tablet: 50 mg

Diclofenac Injectable ampoule: 25 mg/ml, in 3 ml

Ibuprofen Tablet: 400 mg

M03. MUSCLE RELAXANTS M03A. MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS

Suxamethonium Injectable solution: 50 mg/ml, in 2 ml ampoule

Vecuronium bromide Injectable solution: 10 mg/ml, in 10 ml ampoule

N. NERVOUS SYSTEM N01. ANESTHETICS N01A. ANESTHETICS, GENERAL

Halothane Inhalation solution: in 250 ml bottle

Ketamin Injectable solution: 50 mg/ml, in 10 ml vial

Propofol Injectable solution: 10 mg/ml in 20 ml ampoule

Propofol Injectable solution: 10 mg/ml in 100 ml ampoule

Thiopental sodium Injectable powder: 500 mg per vial

N01B. ANESTHETICS, LOCAL

Bupivacaine Injectable solution: 0.5 %, in 10 ml ampoule

Lidocaine Topical gel: 2% in 15 g tube



Lidocaine Injectable ampoule: 1% in 2 ml ampoule

Lidocaine Injectable solution: 2% in 2 ml ampoule

N02. ANALGESICS N02A. OPIOIDS

Morphine (sulfate, hydrochloride) Injectable solution: 10mg/ml, in 1 ml ampoule

Pentazocine Injectable ampoule: 30 mg/ml in 1 ml ampoule

Tramadol Capsule: 50 mg

Tramadol Injectable solution: 50 mg/ml, in 2ml ampoule

N02B. OTHER ANALGESICS AND ANTIPYRETICS

Paracetamol (Acetaminophen) Tablet: 500 mg

Paracetamol (Acetaminophen) Injectable ampoule: 225mg/3ml

N03. ANTIEPILEPTICS N03A. ANTIEPILEPTICS

Phenobarbital Tablet: 100 mg

Phenobarbital Injectable ampoule: 100 mg/ml, in 2 ml ampoule

N05. PSYCHOLEPTICS N05B. ANXIOLYTICS

Alprazolam Tablet: 0.5 mg

Diazepam Tablet: 2 mg



Diazepam Injectable solution: 5 mg/ml in 2 ml

N07. OTHER NERVOUS SYSTEM MEDICINES N07A. PARASYMPATHOMIMETICS

Neostigmine methyl sulfate Injectable ampoule: 0.5 mg/ml, in 10 ml ampule

P. ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

P01. ANTIPROTOZOALS P01A. AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES



Metronidazole Tablet: 400 mg

P02. ANTHELMINTICS P02C. ANTINEMATODAL AGENTS

Albendazole Tablet: 200 mg

Albendazole Tablet: 400 mg

R. RESPIRATORY SYSTEM R03. DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES R03A. ADRENERGICS, INHALANTS

Salbutamol Inhalation solution: 0.1 mg/dose in 200 doses

Salbutamol Nebulizer solution: 5 mg/ml

R03B. OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS

Beclometasone dipropionate Inhalation aerosol: 50 mcg per dose

Beclometasone dipropionate Inhalation aerosol: 250 mcg per dose

Beclometasone dipropionate Nebulizer Solution: 800 mcg/2ml

Ipratropium Inhaler Spray: 40 mcg/dose

Ipratropium Nebulizer Solution: 250 mcg/ml

R03C. ADRENERGICS FOR SYSTEMIC USE

Salbutamol Injectable ampoule: 0.05 mg/ml, in 5 ml ampoule

Salbutamol Injectable ampoule: 0.5mg/ml, in 1 ml ampoule

Terbutaline Injectable solution: 0.5 mg/ml, in 2 ml ampoule

R03D . OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES

Aminophylline Tablet: 100 mg

Aminophylline Injectable solution: 25 mg/ml, in 10 ml ampoule

Montelukast Tablet: 10 mg

Theophylline Tablet: 100 mg



V. VARIOUS

V03. ALL OTHER THERAPEUTIC PRODUCTS – ANTIDOTES V03A. ALL OTHER THERAPEUTIC PRODUCTS

Atropine sulfate Injectable ampoule: 1 mg/ml, in 1 ml ampoule

Naloxone Injectable solution: 400 mcg/ml in 1 ml ampoule

Oxygen Inhalation gas

Protamine sulphate Injectable solution: 10 mg/ml, in 5 ml ampoule

V07. ALL OTHER NON-THERAPEUTIC PRODUCTS V07A. ALL OTHER NONTHERAPEUTIC PRODUCTS

Water for Injection Injectable solution: 5 ml

Water for Injection Injectable solution: 10 ml

V08. CONTRAST MEDIA V08B. X-RAY CONTRAST MEDIA, NON-IODINATED

Barium sulfate Solution: 30% parenteral aqueous solution

V99. UNCLASSIFIED V99A. DENTAL AND DISPENSARY ITEMS

Ethanol 96% liquid



APPENDIX A. BODY SURFACE AREA AND MEDICINE DOSAGE

______________________

Body surface area in m2 = √ {height (cm) x weight (kg)}

3600 Thus a child weighing 10 kg and 72 cm long has a body surface area of

45.00)(10x72/360

Table A1. Drug Dosage by surface area (m2) of the child

Age or weight of child Surface area ________________________________________________

Neonate (< 1 month) 0.2–0.25 m2 ________________________________________________

Young infant (1–<3 months) 0.25–0.35 m2 ________________________________________________

Child 5–9 kg 0.3–0.45 m2 ________________________________________________

Child 10–14 kg 0.45–0.6 m2 ________________________________________________

Child 15–19 kg 0.6–0.8 m2 ________________________________________________

Child 20–24 kg 0.8–0.9 m2 ________________________________________________

Child 25–29 kg 0.9–1.1 m2 ________________________________________________

Child 30–39 kg 1.1–1.3 m2 ________________________________________________

Note: Example if the recommended dose is given as 400 mg/m2 twice per day, then a child in the weight range of 15–19 kg should receive the recommended dose of (0.6–0.8) x 400 = 244–316 mg twice per day

Source: Hospital Care for Children, World Health Organization



APPENDIX B. COMPARISON OF PERCENTAGE WITH RATIO, TEMPERATURE,

WEIGHT, VOLUME, LENGTH

Length

1 meter = 100 centimeters = 1,000 millimeters 10 millimeters = 1 centimeter

Temperature Conversion

°C x 9/5 + 32 = °F

(°F − 32) x 5/9 = °C

Weight

1 gram = 1,000 milligrams 1 milligram = 1,000 micrograms 1 kilogram = 1,000 grams

1 kilogram = 2.2 pounds 1 pound = 6 ounces

Comparison of Percentage and Ratio

1:100 1:200

= 1g/100ml [10mg/ml] = 500mg/100ml [5mg/ml]

= 1%

= 0.5%

1:1,000 1:5,000

= 100mg/100ml [1mg/ml] = 20mg/100ml [200mcg/ml]

= 0.1%

= 0.02%

1:10,000 = 10mg/100ml [100mcg/ml] = 0.01%



Volume

1,000 cubic millimeters = 1 cubic centimeter 1,000 cubic centimeters = 1 cubic decimeter

1,000 cubic decimeters = 1 cubic meter

10 deciliters = 1 liter 1 liter = 1,000 milliliters

10 centiliters = 1 deciliter

1 liter 1,000 milliliters 1 quart / 32 ounces / 2 pints 500 milliliters 1 pint / 16 ounces / 2 cups 240 milliliters 1 cup / 8 ounces 30 milliliters 1 ounce 15 milliliters 1 tablespoon / 3 teaspoons 5 milliliters 15 drops 0.0667 milliliters 1 drop

Source: Simmers, Louise. Diversified Health Occupations (OR Introduction to Health Science

Technology). Delmar, Latest edition.

Formulary List of IbnSina Chest Hospital


APPENDIX C. WEIGHT PER HEIGHT

Height Estimated Lean Body Weight

(+) or ( - ) 2.3 kg per inch over/under 5 feet tall (+) 50 kg for men or (+) 45.5 kg for women

Imperial / metric Males (kg) Females (kg)

4 ft 8 in / 142 cm 40.8 36.3

4 ft 9 in / 145 cm 43.1 38.6

4 ft 10 in / 147 cm 45.4 40.9

4 ft 11 in / 150 cm 47.7 43.2

5 ft 0 in / 152 cm 50.0 45.5

5 ft 1 in / 155 cm 52.3 47.8

5 ft 2 in / 157 cm 54.6 50.1

5 ft 3 in / 160 cm 56.9 52.4

5 ft 4 in / 163 cm 59.2 54.7

5 ft 5 in / 165 cm 61.5 57.0

5 ft 6 in / 168 cm 63.8 59.3

5 ft 7 in / 170 cm 66.1 61.6

5 ft 8 in / 173 cm 68.4 63.9

5 ft 9 in / 175 cm 70.7 66.2

5 ft 10 in / 178 cm 73.0 68.5

5 ft 11 in / 180 cm 75.3 70.8

6 ft 0 in / 183 cm 77.6 73.1

6 ft 1 in / 185 cm 79.9 75.4

6 ft 2 in / 188 cm 82.2 77.7

6 ft 3 in / 191 cm 84.5 80.0

6 ft 4 in / 193 cm 86.8 82.3

6 ft 5 in / 196 cm 89.1 84.6

6 ft 6 in / 198 cm 91.4 86.9

6 ft 7 in / 201 cm 93.7 89.2

6 ft 8 in / 203 cm 96.0 91.5



INDEX A

Acetylsalicylic acid (Aspirin) (ASA) [B01A]

Adenosine [C01E]

Albendazole [P02C]

Aluminium hydroxide + magnesium trisilicate [A02A]

Alprazolam [N05B]

Amikacin [J01G]

Amiloride [C03E]

Amino acid 10% [B05B]

Aminophylline [R03D]

Amiodarone [C01B]

Amlodipine [C08C]

Amoxicillin [J01C]

Amoxicillin + Clavulanic acid (Co-amoxiclav) [J01C]

Ampicillin [J01C]

Atenolol [C07A]

Atorvastatin [C10A]

Atropine sulfate [V03A]

Azithromycin [J01F]

B

Barium sulfate [V08B]

Beclometasone [R03B]

Bisoprolol [C07A]

Bupivacaine [N01B]

C

Candesartan [C09C]

Captopril [C09A]

Carbimazole [H03B]

Carvedilol [C07A]

Cefepime [J01D]

Cefixime [J01D]

Cefotaxime [J01D]

Ceftriaxone [J01D]

Chlorhexidine digluconate [D08A]

Chloroxylenol [D08A]

Ciprofloxacin [J01M]

Clarithromycin [J01F]

Clindamycin [J01F]

Clopidogrel [B01A]

Cloxacillin [J01C]



D

Dexamethasone [H02A]

Diazepam [N05B]

Diclofenac [M01A]

Digoxin [C01A]

Diltiazem [C08D]

Dobutamine [C01C]

Dopamine [C01C]

Doxycyclin [J01A]

E

Enalapril [C09A]

Enoxaparin [B01A]

Epinephrine [C01C]

Ethambutol (E) [J04A]

Ethanol 96% [V99A]

F

Ferrous sulfate (strength in Fe equivalent) + Folic acid [B03A]

Fresh-frozen plasma [B05A]

Furosemide [C03C]

G

Gentamicin [J01G]

Glucose [B05B; B05C]

Glucose + Sodium chloride [B05B]

Glyceryl trinitrate (Nitroglycerin) [C01D]

H

Halothane [N01A]

Heparin [B01A]

Hydralazine [C02D]

Hydrochlorothiazide [C03A]

Hydrochlorothiazide + lisinopril [C09B]

Hydrochlorothiazide + losartan [C09D]

Hydrocortisone sodium succinate [H02A]

Hyoscine [A03B]

I

Ibuprofen [M01A]



Insulin isophane (NPH) intermediate [A10A]

Insulin isophane (NPH) + Regular [A10A]

Ipratropium [R03B]

Isoniazid (H) [J04A]

Isosorbide dinitrate [C01D]

K

Ketamine [N01A]

L

Labetalol [C07A]

Lactulose [A06A]

Levofloxacin [J01M]

Levothyroxine [H03A]

Lidocaine [D04A; N01B]

Losartan [C09C]

M

Mannitol [B05B]

Metformin [A10B]

Methylprednisolone [H02A]

Metoclopramide [A03F]

Metoprolol [C07A] Metronidazole [J01X; P01A]

Montelukast [R03D]

Morphine hydrochloride [N02A]

Moxifloxacin [J01M]

Multivitamins and other minerals, including combinations [A11A]

Multivitamins, other combinations [A11A]

N

Nalidixic Acid [J01M] Naloxone [V03A]

Neostigmine methyl sulfate [N07A]

Nifedipine [G02C]

Nitrofurantoin [J01X]

Norepinephrine [C01C]

O

Omeprazole [A02B]

Oxygen [V03A]



P

Pantoprazole [A02B]

Paracetamol (Acetaminophen) [N02B]

Paraffin liquid [A06A]

Penicillin Benzyl Benzathine [J01C]

Penicillin Benzyl (Peni G) [J01C]

Penicillin V (Phenoxy methyl Penicillin) [J01C]

Pentazocine [N02A]

Phenobarbital [N03A]

Phytomenadione (Vit K) [B02B]

Piperacillin + tazobactam [J01C]

Povidone iodine [D08A]

Prednisolone [H02A]

Propofol [N01A]

Propranolol [C07A]

Protamine sulphate [V03A]

Pyrazinamide (Z) [J04A]

R

Ramipril [C09A]

Ranitidine [A02B]

Reteplase [B01A]

Rifampicin (R) [J04B]

Ringer lactate (Compound Sodium Lactate Solution) [B05B]

Rosuvastatin [C10A]

S

Salbutamol [R03A; R03C]

Sodium bicarbonate [B05C]

Sodium chloride [B05B]

Sodium hypochlorite (Chlorine) [D08A]

Spironolactone [C03D]

Spironolactone + Furosemide [C03E]

Streptokinase [B01A]

Suxamethonium [M03A]

T

Terbutaline [R03C]

Theophylline [R03D]

Thiopental sodium [N01A]

Tramadol [N02A]

Tranexamic acid [B02A]



V

Vecuronium bromide [M03A]

Verapamil [C08D]

W

Warfarin [B01A]

Water for Injection [V07A]

indira gandhi child health institute formulary list...ministry of public health general directorate...

Documents